Heparin-associated thrombocytopenia: a comparison of three heparin preparations.
about
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patientsHeparin-induced thrombocytopenia, thrombosis, and hemorrhageHeparin-induced thrombocytopenia: natural history, diagnosis, and management.Dipyridamole in the Management of Severe Heparin-associated Thrombocytopenia.Heparin-induced thrombocytopenia: a case report.Why is the platelet count low: should I be concerned about heparin-induced thrombocytopenia?Heparin-induced thrombocytopenia. A common but controllable condition.Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia--a case report.Treatment of venous thromboembolic disease. A pragmatic approach to anticoagulation and thrombolysis.Inaccurate assessment of drug-induced thrombocytopenia: reason for concern.Heparin-associated thrombocytopenia and thrombosis (HATT) presenting with livedo reticularis.Effects of heparin on platelet aggregation and release and thromboxane A2 production.Synergistic effect of heparin and chemotactic factor on polymorphonuclear leukocyte aggregation and degranulation.Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units/day) in the treatment of patients with acute coronary event--first year and long-term comparative mortality.Hemostatic defects in cancer patients.Quantitative PCR and disaccharide profiling to characterize the animal origin of low-molecular-weight heparins.Validation of quantitative polymerase chain reaction methodology for monitoring DNA as a surrogate marker for species material contamination in porcine heparin.
P2860
Q24200589-AFF74F7B-9373-4800-A409-46A746E5BAA5Q28366919-A230A721-C7B6-4110-AB43-E77DEC6A795DQ33338785-97185CFD-9365-4DC4-B269-C44186173DFDQ33392636-EC46384D-E96E-4302-B3F3-2E0B8F38DCE8Q33402278-92CCD29C-2376-48B3-B501-61A027DB6EBEQ33404176-CF154298-2A40-4C0E-8A1E-D54517F3229DQ33429312-01F4CD55-8C95-44A6-B38E-90649EF6287BQ33441234-499A55A9-0D40-4CB0-BD47-6BE05915B393Q33448108-4E5995F0-46A0-4D24-9F0B-561FCC35A56BQ33455599-60F18D11-5EB3-4BC8-8726-E2F0F6EBAA4FQ33490900-A00DE6E3-6B8A-46C6-A766-D3206E810EA8Q33494734-DB3804E0-FDA6-4FC9-B7EB-AEC81E32C14FQ35863908-4528B312-C235-4041-BC36-B8CF10C7E614Q35885740-C7CE79DE-CBA7-455B-A9F3-CC27FDE00A0DQ36518674-E90DEAF8-0FAB-4AEB-BF45-BBF1F0FCC805Q39127942-B163BA4D-B560-4520-B8FB-575EB450DCE6Q46043404-907396BA-5CD7-4DCA-B326-03FD4774B6CCQ54307520-30B777F8-76E9-496C-B816-88363123553F
P2860
Heparin-associated thrombocytopenia: a comparison of three heparin preparations.
description
1980 nî lūn-bûn
@nan
1980 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Heparin-associated thrombocytopenia: a comparison of three heparin preparations.
@ast
Heparin-associated thrombocytopenia: a comparison of three heparin preparations.
@en
type
label
Heparin-associated thrombocytopenia: a comparison of three heparin preparations.
@ast
Heparin-associated thrombocytopenia: a comparison of three heparin preparations.
@en
prefLabel
Heparin-associated thrombocytopenia: a comparison of three heparin preparations.
@ast
Heparin-associated thrombocytopenia: a comparison of three heparin preparations.
@en
P1476
Heparin-associated thrombocytopenia: a comparison of three heparin preparations.
@en
P2093
P304
P356
10.1056/NEJM198010163031602
P407
P577
1980-10-01T00:00:00Z